IGFBP7 protects against endothelial apoptosis and blood–brain barrier disruption following oxygen–glucose deprivation/reoxygenation
Brain Research · 2026
DOI: 10.1016/j.brainres.2026.150254 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2026. Verfasst von Yuyi Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Center of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu 610041, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Apoptosis, Endothelial Cells, Insulin-Like Growth Factor Binding Proteins. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Chengdu Science and Technology Bureau, National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND: The blood-brain barrier (BBB) is a critical interface maintained by cerebral microvascular endothelial cells, which rely on tight junction (TJ) proteins like ZO-1 and occludin to regulate permeability. Following ischemic stroke, BBB disruption and subsequent cerebral edema are major contributors to poor clinical outcomes. Insulin-like growth factor-binding protein 7 (IGFBP7) is highly expressed in these endothelial cells and has been implicated in both BBB formation and vascular repair. However, its specific role in stroke-induced endothelial injury has remained inconclusive. METHODS AND RESULTS: In this study, we investigated the function of IGFBP7 in an in vitro model of oxygen-glucose deprivation and reoxygenation (OGD/R) using mouse microvascular endothelial (bEnd.3) cells. We manipulated IGFBP7 levels through overexpression and siRNA-mediated silencing. Our results show that OGD/R treatment significantly decreased IGFBP7 expression, which led to increased BBB permeability, degradation of tight junction proteins, and cellular apoptosis. Importantly, overexpressing IGFBP7 mitigated these effects, restoring the expression of ZO-1 and reducing apoptosis. Conversely, silencing IGFBP7 exacerbated both tight junction protein degradation and cell apoptosis. CONCLUSION: Endothelial IGFBP7 exerts a protective role in ischemic stroke by blunting OGD/R-mediated BBB damage and thus, it may represent an interesting novel therapeutic target to be explored in future clinical investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology and Center of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu 610041, China.
- Department of Neurosurgery, West China School of Medicine/West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: simaxiutian@scu.edu.cn.
- Department of Neurology and Center of Cerebrovascular Diseases, West China Hospital, Sichuan University, Chengdu 610041, China; Microbiology and Intelligent Biomanufacturing Key Laboratory of Sichuan Province, Chengdu 6…
Förderung
- Chengdu Science and Technology Bureau
- National Natural Science Foundation of China
Zitieren
APA
Zhu, Y., Cui, T., Chen, M., Xu, M., Sima, X., & Wang, D. (2026). IGFBP7 protects against endothelial apoptosis and blood–brain barrier disruption following oxygen–glucose deprivation/reoxygenation. Brain Research. https://doi.org/10.1016/j.brainres.2026.150254
Vancouver
Zhu Y, Cui T, Chen M, Xu M, Sima X, Wang D. IGFBP7 protects against endothelial apoptosis and blood–brain barrier disruption following oxygen–glucose deprivation/reoxygenation. Brain Research. 2026. doi:10.1016/j.brainres.2026.150254
BibTeX
@article{Zhu2026,
author = {Zhu, Yuyi and Cui, Ting and Chen, Mingxi and Xu, Mangmang and Sima, Xiutian and Wang, Deren},
title = {IGFBP7 protects against endothelial apoptosis and blood–brain barrier disruption following oxygen–glucose deprivation/reoxygenation},
journal = {Brain Research},
year = {2026},
doi = {10.1016/j.brainres.2026.150254}
}
EUVIMED